Add to ORKGWe conducted a placebo-controlled, double-blind, randomized study to evaluate the microbiological efficacy and safety of inhaled tobramycin for treatment of patients with bronchiectasis and Pseudomonas aeruginosa. Patients were randomly assigned to re-ceive either tobramycin solution for inhalation (TSI) (n
International guidelines on the treatment of bronchiectasis indicate that the use of inhaled antibio...
Bronchiectasis is a final common pathway of a wide variety of underlying conditions including infect...
Introduction: Until recently considered as a minor health problem, the role of bronchiectasis is now...
Background: Inhaled antibiotics have been incorporated into contemporary European and British guidel...
Background: Inhaled antibiotics have been incorporated into contemporary European and British guidel...
In patients with bronchiectasis (BE), infection with Pseudomonas aeruginosa (Pa) results in disease ...
In patients with bronchiectasis (BE), infection with Pseudomonas aeruginosa (Pa) results in disease ...
The study aimed to determine the efficacy of a safe and well-Tolerated dose and regimen of tobramyci...
There is currently less experience with inhaled tobramycin in non-cystic fibrosis bronchiectasis tha...
Therapies shown to be effective in cystic fibrosis are often provided to patients with bronchiectasi...
<div><p>Rationale</p><p>Bronchiectasis is a condition characterised by dilated and thick-walled bron...
In patients with cystic fibrosis (CF), chronic bronchial infec-tion with Pseudomonas aeruginosa (PA)...
Aminoglycosides are effective against Pseudomonas aeruginosa but with intravenous administration the...
AbstractThe aim of this study was to investigate the long-term effectiveness and safety of inhaled a...
International guidelines on the treatment of bronchiectasis indicate that the use of inhaled antibio...
Bronchiectasis is a final common pathway of a wide variety of underlying conditions including infect...
Introduction: Until recently considered as a minor health problem, the role of bronchiectasis is now...
Background: Inhaled antibiotics have been incorporated into contemporary European and British guidel...
Background: Inhaled antibiotics have been incorporated into contemporary European and British guidel...
In patients with bronchiectasis (BE), infection with Pseudomonas aeruginosa (Pa) results in disease ...
In patients with bronchiectasis (BE), infection with Pseudomonas aeruginosa (Pa) results in disease ...
The study aimed to determine the efficacy of a safe and well-Tolerated dose and regimen of tobramyci...
There is currently less experience with inhaled tobramycin in non-cystic fibrosis bronchiectasis tha...
Therapies shown to be effective in cystic fibrosis are often provided to patients with bronchiectasi...
<div><p>Rationale</p><p>Bronchiectasis is a condition characterised by dilated and thick-walled bron...
In patients with cystic fibrosis (CF), chronic bronchial infec-tion with Pseudomonas aeruginosa (PA)...
Aminoglycosides are effective against Pseudomonas aeruginosa but with intravenous administration the...
AbstractThe aim of this study was to investigate the long-term effectiveness and safety of inhaled a...
International guidelines on the treatment of bronchiectasis indicate that the use of inhaled antibio...
Bronchiectasis is a final common pathway of a wide variety of underlying conditions including infect...
Introduction: Until recently considered as a minor health problem, the role of bronchiectasis is now...